| Proteogenomics connects somatic mutations to signalling in breast cancer P Mertins, DR Mani, KV Ruggles, MA Gillette, KR Clauser, P Wang, ... Nature 534 (7605), 55-62, 2016 | 1316 | 2016 |
| Proteogenomic characterization of human colon and rectal cancer B Zhang, J Wang, X Wang, J Zhu, Q Liu, Z Shi, MC Chambers, ... Nature 513 (7518), 382-387, 2014 | 1247 | 2014 |
| Multi-site assessment of the precision and reproducibility of multiple reaction monitoring–based measurements of proteins in plasma TA Addona, SE Abbatiello, B Schilling, SJ Skates, DR Mani, DM Bunk, ... Nature biotechnology 27 (7), 633-641, 2009 | 1073 | 2009 |
| Integrated proteogenomic characterization of human high-grade serous ovarian cancer H Zhang, T Liu, Z Zhang, SH Payne, B Zhang, JE McDermott, JY Zhou, ... Cell 166 (3), 755-765, 2016 | 744 | 2016 |
| Promoting coherent minimum reporting guidelines for biological and biomedical investigations: the MIBBI project CF Taylor, D Field, SA Sansone, J Aerts, R Apweiler, M Ashburner, ... Nature biotechnology 26 (8), 889-896, 2008 | 592 | 2008 |
| Repeatability and reproducibility in proteomic identifications by liquid chromatography− tandem mass spectrometry DL Tabb, L Vega-Montoto, PA Rudnick, AM Variyath, AJL Ham, DM Bunk, ... Journal of proteome research 9 (2), 761-776, 2010 | 558 | 2010 |
| Targeted peptide measurements in biology and medicine: best practices for mass spectrometry-based assay development using a fit-for-purpose approach SA Carr, SE Abbatiello, BL Ackermann, C Borchers, B Domon, ... Molecular & Cellular Proteomics 13 (3), 907-917, 2014 | 504 | 2014 |
| Proteogenomic analysis of human colon cancer reveals new therapeutic opportunities S Vasaikar, C Huang, X Wang, VA Petyuk, SR Savage, B Wen, Y Dou, ... Cell 177 (4), 1035-1049. e19, 2019 | 397 | 2019 |
| Integrated proteogenomic characterization of clear cell renal cell carcinoma DJ Clark, SM Dhanasekaran, F Petralia, J Pan, X Song, Y Hu, ... Cell 179 (4), 964-983. e31, 2019 | 290 | 2019 |
| Proteogenomic characterization reveals therapeutic vulnerabilities in lung adenocarcinoma MA Gillette, S Satpathy, S Cao, SM Dhanasekaran, SV Vasaikar, K Krug, ... Cell 182 (1), 200-225. e35, 2020 | 274 | 2020 |
| Connecting genomic alterations to cancer biology with proteomics: the NCI Clinical Proteomic Tumor Analysis Consortium MJ Ellis, M Gillette, SA Carr, AG Paulovich, RD Smith, KK Rodland, ... Cancer discovery 3 (10), 1108-1112, 2013 | 214 | 2013 |
| Proteogenomic characterization of endometrial carcinoma Y Dou, EA Kawaler, DC Zhou, MA Gritsenko, C Huang, L Blumenberg, ... Cell 180 (4), 729-748. e26, 2020 | 202 | 2020 |
| Proteogenomic and metabolomic characterization of human glioblastoma LB Wang, A Karpova, MA Gritsenko, JE Kyle, S Cao, Y Li, D Rykunov, ... Cancer cell 39 (4), 509-528. e20, 2021 | 191 | 2021 |
| Recommendations for the generation, quantification, storage, and handling of peptides used for mass spectrometry–based assays AN Hoofnagle, JR Whiteaker, SA Carr, E Kuhn, T Liu, SA Massoni, ... Clinical chemistry 62 (1), 48-69, 2016 | 181 | 2016 |
| Performance metrics for liquid chromatography-tandem mass spectrometry systems in proteomics analyses PA Rudnick, KR Clauser, LE Kilpatrick, DV Tchekhovskoi, P Neta, ... Molecular & Cellular Proteomics 9 (2), 225-241, 2010 | 181 | 2010 |
| Interlaboratory study characterizing a yeast performance standard for benchmarking LC-MS platform performance AG Paulovich, D Billheimer, AJL Ham, L Vega-Montoto, PA Rudnick, ... Molecular & Cellular Proteomics 9 (2), 242-254, 2010 | 172 | 2010 |
| Large-scale interlaboratory study to develop, analytically validate and apply highly multiplexed, quantitative peptide assays to measure cancer-relevant proteins in plasma SE Abbatiello, B Schilling, DR Mani, LJ Zimmerman, SC Hall, B MacLean, ... Molecular & Cellular Proteomics 14 (9), 2357-2374, 2015 | 168 | 2015 |
| Proteogenomic landscape of breast cancer tumorigenesis and targeted therapy K Krug, EJ Jaehnig, S Satpathy, L Blumenberg, A Karpova, M Anurag, ... Cell 183 (5), 1436-1456. e31, 2020 | 157 | 2020 |
| CPTAC Assay Portal: a repository of targeted proteomic assays JR Whiteaker, GN Halusa, AN Hoofnagle, V Sharma, B MacLean, P Yan, ... Nature methods 11 (7), 703-704, 2014 | 136 | 2014 |
| Proteogenomic integration reveals therapeutic targets in breast cancer xenografts K Huang, S Li, P Mertins, S Cao, HP Gunawardena, KV Ruggles, ... Nature communications 8 (1), 14864, 2017 | 132 | 2017 |
